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Introduction {#sec006}
============

The prevalence of asthma and atopy has increased considerably over the last few decades in Western countries \[[@pone.0131594.ref001]\]. Development of these diseases seems more pronounced in children who live in cities compared to children who live on farms \[[@pone.0131594.ref002]--[@pone.0131594.ref003]\]. However, the causes of the lower risk for developing allergic diseases have been elucidated only partially and mechanisms that explain this protective 'farm effect' have not been unravelled in detail. There is evidence that exposure to microbes and microbial components may be responsible for the protective quality of growing up on a farm---by triggering the innate immune system and influencing T-cell regulation---but associations found for different microbial agents have not always been consistent across different studies \[[@pone.0131594.ref004]--[@pone.0131594.ref009]\]. It has been suggested that several independent microbial signals may play a role in activating the protective effects of farm environments \[[@pone.0131594.ref010]\]. More recently, diversity of microbial exposure has been associated with a reduced risk of asthma in population studies \[[@pone.0131594.ref011]\].

Here, we present a comprehensive approach combining qualitative analysis of bacterial profiles in house dust of children in rural areas with a second, quantitative methodology to confirm the initial findings. Specifically the confirmatory aspect of this work is advancement beyond previous studies on the relevance of microbial factors in asthma and allergy.

Methods {#sec007}
=======

Samples and study design {#sec008}
------------------------

The GABRIEL Advanced survey is an interdisciplinary study designed to identify the genetic and environmental causes of asthma in the European Community. The study design has been described previously \[[@pone.0131594.ref012]\] and is detailed in the supporting information. In brief, the main survey consisted of a weighted stratified random sample of a general population sample drawn from rural areas in Germany, Austria and Switzerland. Exposure strata were defined as (i) farm children, who lived on an operating farm; (ii) exposed non-farm children, who did not qualify as farm children but had regularly contact with farms and/or consumed farm milk; and (iii) unexposed non-farm children. For the current study, disproportionate random samples were drawn within each of the aforementioned exposure groups stratified by disease into asthmatic, non-asthmatic atopic, and non-asthmatic non-atopic children. Disproportionate sampling was used to increase statistical power for the analyses of the main characteristics under investigation: exposure to farming environments, asthma and atopy.

Mattress dust samples of 224 children aged 6--12 years were used in this analysis. General characteristics of the study population are described in [Table 1](#pone.0131594.t001){ref-type="table"}. The dust samples were provided by the parents using a standardised dust collection protocol \[[@pone.0131594.ref013]\] which included photo instructions. The whole mattress was vacuumed for a period of 2 minutes, with a dust sampling nylon sock attached to the vacuum cleaner hose. The dust samples were stored at -80°C or below upon arrival at the study centre.

10.1371/journal.pone.0131594.t001

###### General characteristics of the study population (n = 224).

![](pone.0131594.t001){#pone.0131594.t001g}

                                                                      FARM CHILDREN     EXPOSED NON-FARM CHILDREN   NON-EXPOSED NON-FARM CHILDREN                                                                                             
  ------------------------------------------------------------------- ----------------- --------------------------- ------------------------------- ----------------- ----------------- ----------------- ----------------- ----------------- -----------------
  N                                                                   32                23                          19                              32                22                21                32                21                22
  Child sex (F/M)                                                     10 / 22           10 / 13                     13 / 6                          12 / 20           12 / 10           6 / 15            11 / 21           5 / 16            9 / 13
  Age mean (min-max)                                                  9.5 (7.5--11.4)   9.6 (7.4--11.3)             9.6 (7.5--11.4)                 9.6 (7.3--11.5)   9.5 (7.4--11.3)   9.5 (7.4--11.5)   9.2 (7.1--11.0)   9.3 (7.8--11.2)   9.3 (7.3--11.5)
  No of siblings(0--1 sibling / more than 1 sibling) %                50 / 50           43.5 / 46.5                 42.1 / 57.9                     83.9 / 16.1       63.6 / 36.4       57.1 / 42.9       65.6 / 34.4       61.9 / 38.1       77.3 / 22.7
  Parental smoking (no smoking / one or both parents are smoking) %   78.1 / 21.9       91.3 / 8.7                  61.1 / 38.9                     69.0 / 31.0       81.8 / 18.2       57.1 / 42.9       71.0 / 29.0       71.4 / 28.6       76.2 / 23.8

Written informed consent was obtained from the parents or guardians of all children participating in the study. Ethical approval was obtained from the ethics committees of the participating universities; Bavarian Medical Association, Ulm University, the cantons Luzern, Zurich and Thurgau, Medical University of Innsbruck and Medical University of Wroclaw. The data protection concept was approved by the regional data protection authorities (Baden-Württenberg) \[[@pone.0131594.ref012]\].

Profiling bacterial communities {#sec009}
-------------------------------

DNA was isolated from 20 mg accurately weighed (SBA 31, Scaltec) mattress dust with bead beating (Glass beads 212--300 μm, Sigma Aldrich). 2 × 10^6^ spores of *Geotrichum candidum* (UAMH 7863) strain were added to the samples as an internal control (see [S1 Text](#pone.0131594.s004){ref-type="supplementary-material"} for use of the internal control in calculation of qPCR results). Bead milling was followed by extraction using GenElute Plant kit (Sigma-Aldrich, Germany). Fingerprints of the bacterial communities were produced using target DNA amplification by PCR followed by DGGE \[[@pone.0131594.ref014]\]. Ultimately, each separate band in the generated, bacterial DNA fingerprints represents a distinct bacterium/bacterial group, so-called \"bacterial taxonomic units\". DNA bands were stained, visualised and the fingerprints were documented by photographing. The images were analysed with Bionumerics (version 4.61) software. A detailed description of the molecular biological analyses is provided in the supporting information ([S1 Text](#pone.0131594.s004){ref-type="supplementary-material"}).

The presence of individual bands in the mattress dust samples were associated to respiratory and allergic symptoms indicative of asthma and atopy, serum IgE levels and farm exposures. A complete list of the health and exposure variables used in the statistical analysis is provided in [S1 Table](#pone.0131594.s001){ref-type="supplementary-material"}. Three major health endpoints were analysed using several questions or data variables: asthma (6 variables); atopy (5 variables); and eczema (2 variables). In addition, 19 different variables defining farm-related exposures were used (see below details on statistical methods).

Confirmation studies using quantitative PCR {#sec010}
-------------------------------------------

Selected bands were isolated from the DNA fingerprints and subjected to a process resulting in obtaining sequence information of the respective bacterial groups, allowing for the identification of the bacterial signals (detailed in the supporting information, [S1 Text](#pone.0131594.s004){ref-type="supplementary-material"}). In order to obtain confirmation of associations between bacterial groups in the DNA fingerprints and health outcomes, we applied a second, quantitative approach. Quantitative PCR (qPCR) assays targeting bacterial groups of interest were optimized ([S1 Text](#pone.0131594.s004){ref-type="supplementary-material"}, [S2 Table](#pone.0131594.s002){ref-type="supplementary-material"}). qPCR analyses were applied to the original dust samples in order to obtain a quantitative measure for the following bacterial groups: *Mycobacterium* spp., *Bifidobacteriaceae* spp., *Clostridium* spp. cluster I and *Clostridium* spp. cluster XI. Associations of qPCR levels with doctor-diagnosed asthma and atopy were explored.

Statistical methods {#sec011}
-------------------

Associations between DGGE band density, and health and exposure variables ([S1 Table](#pone.0131594.s001){ref-type="supplementary-material"}) were analysed using Tobit regression to obtain an unbiased estimate of the average differences in band density given the many non-detects \[[@pone.0131594.ref015]--[@pone.0131594.ref016]\]. Density of the DGGE bands determined in Bionumerics software was used as a semi-quantitative measure, assuming differences in band densities represent relative differences in bacterial levels, as previously suggested to be the case for the DGGE method \[[@pone.0131594.ref014],[@pone.0131594.ref017]\]. Adjustment was made for multiple comparisons by using the False Discovery Rate (FDR) \[[@pone.0131594.ref018]\]. All analyses were back-weighted to a general population sample \[[@pone.0131594.ref012]\]. Principal component analyses were performed for band-density to explore clustering of bands.

Bands with significant associations with doctor-diagnosed asthma or the broad phase 1 asthma definition, and/or atopy \[defined as IgE antibodies against house dust mite, cat, and/or birch allergen (0.7 kU/L), or a positive reaction to the grass mix (0.35 kU/L)\], and/or doctor-diagnosed atopic eczema were selected for band excision, cloning and sequencing (with the exception of one band, as explained in [S1 Text](#pone.0131594.s004){ref-type="supplementary-material"}). Four bands that showed several associations with environmental factors were also sequenced. Then, a limited set of bacterial targets was selected for confirmative qPCR analysis. This selection was based on 1) a protective associations of the DGGE band with asthma and/or atopy and/or eczema as defined above; 2) association with one or more of the environmental exposure variables of interest; and 3) successful band excision and sequence determination.

We assessed the exposure-response relationships between quantitative levels of selected bacterial groups determined via qPCR (log transformed), atopy \[IgE against house dust mite, cat, and/or birch allergen (0.7 kU/L), or a positive reaction to the grass mix (0.35 kU/L)\] and doctor-diagnosed asthma using survey weighted logistic-regression, fitted with a cubic B-splines term, and adjusted for sex. Shannon diversity index \[[@pone.0131594.ref019]\] was also explored by logistic regression and cubic splines. Modelling was performed using R version 3.0.0 (R Foundation for Statistical Computing, Vienna, Austria) using the survey package \[[@pone.0131594.ref020]--[@pone.0131594.ref021]\]. The optimal model was determined by minimizing the Akaike Information Criterion (AIC).

Results {#sec012}
=======

The overall workflow of this study---including DNA fingerprinting of bacteria in house dust; statistical analyses of the DNA signals against health and exposure variables; selection of target signals for in depth studies (further sequencing); and quantitative confirmation of the results via qPCR---is illustrated in [Fig 1](#pone.0131594.g001){ref-type="fig"}.

![Flowchart of the study.\
Flowchart of molecular analyses (DGGE fingerprinting, quantitative PCR), statistical analyses, and the selection of bands for sequencing and qPCR assays.](pone.0131594.g001){#pone.0131594.g001}

DNA fingerprinting {#sec013}
------------------

Altogether, 43 different bacterial bands representing distinct bacterial taxonomic units were found in the mattress dust DNA fingerprints. A median number of 14 bands per sample was found in 214 mattress dust samples with sufficient dust out of 224 samples. Of the 1376 explored relations, 142 had p-values \<0.05. Of these 142, 33 associations remained statistically significantly associated with a health outcome or exposure variable after FDR adjustment. Most of the DGGE band associations with health outcomes were more frequently related to atopy and eczema than to asthma. One exception was band 22, which was strongly protectively associated with asthma and this association survived FDR adjustment. None of the associations with atopy (specific IgE cut point 0.7 kU/L) survived FDR adjustment; associations with hay fever and eczema symptoms survived FDR adjustment in four of the bands (band 29 and 39 associated with hay fever, band 20 and 38 associated with eczema symptoms).

Selection of targets for sequencing {#sec014}
-----------------------------------

In total, 18 bands were subjected to cloning and DNA sequencing ([Table 2](#pone.0131594.t002){ref-type="table"}). We obtained sequence information from 15 of these bands, out of which seven bands showed significant protective or risk associations with doctor diagnosed asthma, and/or atopy, and/or eczema. Sequence information retrieved for such bands pointed towards four distinct bacterial groups or taxonomic units and for those, qPCR assays were applied: *Mycobacterium* spp., *Bifidobacteriaceae* spp., and two different clusters of *Clostridium* spp. (cluster I and cluster XI). The bacterial taxonomic units targeted with qPCR assays were from distinctly different clusters (as tested in principal component analysis), indicating that the selected bands were not clearly statistically associated with each other.

10.1371/journal.pone.0131594.t002

###### Overview of associations between the presence of 43 bacterial taxonomic units (= bands) identified with DNA fingerprinting in mattress dust, and their associations with the health outcomes asthma (6 variables), atopy (5 variables) and eczema (2 variables) and exposure variables (19 variables) (presented are the bands with an association with p\<0.05 in Tobit regression analysis, adjusted for age and sex).
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  Band number                                                                           Health variables   Exposure variables   Selected for sequencing [¤](#t002fn009){ref-type="table-fn"}               
  ------------------------------------------------------------------------------------- ------------------ -------------------- -------------------------------------------------------------- --- --- --- ---
  35                                                                                                                            2 out of 2                                                     x           y
  Protective                                                                                                                                                                                               
  41                                                                                                       3 out of 5                                                                          x       x   y
  Protective                                                                                                                                                                                               
  32                                                                                                       2 out of 5           1 out of 2                                                     x   x       y
  Protective                                                                            Protective                                                                                                         
  36                                                                                                       2 out of 5                                                                          x       x   y
  Protective                                                                                                                                                                                               
  17                                                                                                       2 out of 5                                                                          x           y
  Adverse Risk                                                                                                                                                                                             
  24                                                                                                                            1 out of 2                                                     x       x   y
  Adverse Risk                                                                                                                                                                                             
  8                                                                                     1 out of 6                                                                                             x   x       y
  Protective                                                                                                                                                                                               
  22                                                                                    1 out of 6                                                                                                         y
  Protective                                                                                                                                                                                               
  20                                                                                                                            1 out of 2                                                                 y
  Adverse Risk, 1 out of 2 Protective                                                                                                                                                                      
  26                                                                                                                            1 out of 2                                                     x           y
  Protective                                                                                                                                                                                               
  37                                                                                                       1 out of 5                                                                              x       y
  Protective                                                                                                                                                                                               
  38                                                                                                       2 out of 5           1 out of 2                                                     x       x   y
  Protective                                                                            Protective                                                                                                         
  21                                                                                    1 out of 6                              1 out of 2                                                                 y
  Protective                                                                            Protective                                                                                                         
  46                                                                                    2 out of 6         2 out of 5                                                                          x   x   x   y
  Adverse Risk                                                                          Adverse Risk                                                                                                       
  33                                                                                                                                                                                           x           y
  34                                                                                                                                                                                           x   x       y
  27                                                                                                                                                                                           x       x   y
  25                                                                                                                                                                                           x   x   x   y
  15                                                                                                                            1 out of 2                                                                 
  Protective                                                                                                                                                                                               
  29                                                                                                       1 out of 5                                                                                      
  Protective                                                                                                                                                                                               
  39                                                                                                       2 out of 5                                                                                      
  Protective                                                                                                                                                                                               
  9                                                                                     1 out of 6                                                                                                         
  Protective                                                                                                                                                                                               
  16                                                                                    1 out of 6                                                                                                         
  Protective                                                                                                                                                                                               
  7                                                                                                                                                                                            x           
  14                                                                                                                                                                                           x           
  18                                                                                                                                                                                           x   x       
  23                                                                                                                                                                                           x           
  42                                                                                                                                                                                           x           
  44                                                                                                                                                                                           x           
  45                                                                                                                                                                                           x       x   
  47                                                                                                                                                                                           x       x   
  48                                                                                                                                                                                           x       x   
  11                                                                                                                                                                                               x       
  Nine bands without associations with atopy, asthma or any of the exposure variables                                                                                                                      

\* 'yes' to one or more (n/6) of the following six questionnaire items; broad phase 1 asthma definition \[= reported wheeze (last 12 months or ever), asthma inhaler use ever, or a reported doctor's diagnosis of asthma at least once, or wheezy bronchitis at least twice throughout the lifetime\], doctor-diagnosed asthma, wheeze in the past 12 months, breathing problems and breathing noises, use of inhaler ever or in the past 12 months.

\*\* 'yes' to one or more (n/5) of the following five items; specific IgE serum levels \> 0.35kU/L, specific IgE serum levels \> 0.7 kU/L, rhinitis symptoms in the past 12 months, rhinoconjunctivitis symptoms in the past 12 months, doctor diagnosed hay fever

\*\*\* 'yes' to one or two of the following: doctor diagnosed atopic eczema, eczema symptoms in the past 12 months

^\#^ 'yes'to one or more of the following items: child present during milking; cattle care; littering or removing dung; child spent time regular with animals in the stable

^†^ 'yes' to: has your child drunk milk directly from a farm regularly (at least once a week for 6 months)?

^‡‡^ 'yes' to: child present while the adults were feeding the animals

x = association (direction not defined) at least with one of the questions

y = yes, band selected to sequencing

^¤^ = Bands selected for sequencing had significant association with doctor diagnosed asthma or broad phase 1 asthma definition, and/or atopy (cut point 0.7kU/l), and/or atopic eczema. Bands 33, 34, 27, 25 were selected because of their multiple associations with farming factors.

Sequence information from bands with risk associations were related to the bacterial groups *Sphingomonas* spp. and *Paracoccus* spp. ([Table 3](#pone.0131594.t003){ref-type="table"}).

10.1371/journal.pone.0131594.t003

###### Detailed information on health associations of DGGE bands that were selected for sequencing and taxonomic allocation of sequences retrieved from the bands after database comparison (p-values of associations between DGGE bands and health outcomes are provided both after crude analyses and after FDR adjustment for multiple testing.
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  Band number                                  Associations with health outcomes   p-values    q-values (FDR adjusted)   Sequences retrieved from band with high (≥99%) database similarity   Likely taxonomic allocation
  ------------- ------------------------------ ----------------------------------- ----------- ------------------------- -------------------------------------------------------------------- -----------------------------
  35            Protective                     DD atopic eczema                    0.008       p = 0.099                 *Gardnerella* spp.                                                   *Bifidobacteriaceae*
  Protective    Eczema symptoms                0.002                               p = 0.083                                                                                                  
  41            Protective                     Specific IgE \>0.7 kU/L             0.023                                 *Mycobacterium* spp., *Dietzia* spp.                                 *Corynebacterineae*
  Protective    Specific IgE \>0.35kU/L        0.027                                                                                                                                          
  Protective    DD hay fever                   0.038                                                                                                                                          
  32            Protective                     DD atopic eczema                    0.006       p = 0.061                 *Clostridium* spp.                                                   *Clostridium*
  36            Protective                     Specific IgE \>0.7 kU/L             0.003       p = 0.088                                                                                      *Clostridiaceae*
  Protective    Specific IgE \>0.35kU/L        0.002                                                                                                                                          
  17            Risk                           Specific IgE \>0.7 kU/L             0.016                                 *Sphingomonadaceaea* spp.                                            *Sphingomonadaceae*
  Risk          Specific IgE \>0.35kU/L        0.016                                                                                                                                          
  24            Risk                           DD atopic eczema                    0.040                                 *Paracoccus* spp.                                                    *Paracoccus*
  8             Protective                     DD asthma                           0.025                                 No sequence information                                              
  22            Protective                     broad phase 1 asthma definition     0.008       p = 0.024                 Ambiguous sequence information, no taxonomic allocation              
  20            Risk                           DD eczema                           0.043       p = 0.001                 No sequence information                                              
  Protective    eczema symptoms                0.000                                                                                                                                          
  26            Protective                     eczema symptoms (past 12 mo)        0.032                                 *Clostridiales* spp.                                                 *Clostridiales*
  37            Protective                     rhinoconjunctivitis symptoms        0.040                                 *Psychrobacillus* spp.                                               *Bacillaceae*
  38            Protective                     Rhinoconjunctivitis symptoms        0.016       p = 0.005                 *Rothia* spp.                                                        *Micrococcaceae*
  Protective    DD hay fever                   0.030                                                                                                                                          
  Protective    eczema symptoms                0.003                                                                                                                                          
  21            Protective                     inhaler use                         0.040                                 *Corynebacterium* spp.                                               *Corynebacterium*
  Protective    eczema symptoms                0.035                                                                                                                                          
  46            Risk                           eczema symptoms                     0.022       p = 0.080                 No sequence information                                              
  Risk          rhinoconjunctivitis symptoms   0.024                                                                                                                                          
  Risk          DD hay fever                   0.011                                                                                                                                          
  33                                           No health associations                                                    Ambiguous sequence information, no taxonomic allocation              
  34                                           No health associations                                                    *Actinomycetales* spp.                                               *Actinomycetales*
  27                                           No health associations                                                    *Sphingomonadaceae* spp.                                             *Sphingomonadaceae*
  25                                           No health associations                                                                                                                         *Enterobacteraceae*

Only q-values \< 0.1are shown).

Quantity and diversity of bacterial groups, relation to atopy and asthma {#sec015}
------------------------------------------------------------------------

To confirm findings based on DNA-fingerprinting, the concentrations of four selected bacterial groups---*Mycobacterium* spp., *Bifidobacteriaceae* spp. and two different *Clostridium* spp. groups (cluster I and cluster XI)---were quantified via qPCR. The results presented as cells/mg dust are detailed for the nine exposure and health outcome strata in [Table 4](#pone.0131594.t004){ref-type="table"}. The results are additionally expressed as microbial loads, i.e. cells per mattress area (cells/m^2^) in [S3 Table](#pone.0131594.s003){ref-type="supplementary-material"}. Loads of microbial markers expressed as cells per m^2^ were highly correlated (0.62--0.82, Spearman correlations); correlations for microbial concentrations (cells/mg) where somewhat lower (0.31--0.71, Spearman correlations).

10.1371/journal.pone.0131594.t004

###### Levels of microbes detected using qPCR (cells/mg dust) and diversity metrics in three exposure strata stratified by health outcomes.
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                              FARM CHILDREN      EXPOSED NON-FARM CHILDREN   NON-EXPOSED NON-FARM CHILDREN                                                                                                        
  --------------------------- ------------------ --------------------------- ------------------------------- ---------------- ---------------- ---------------- ---------------- ---------------- --------------- -------
  *Mycobacterium* spp.        Median             5573                        6649                            4927             3679             3989             4527             2284             2720            3343
  (min-max)                   (1217--19031)      (2256--22142)               (1325--13239)                   (573--12070)     (278--18519)     (559--9075)      (311--16741)     (121--6917)      (363--11967)    
  *Bifidobacteriaceae* spp.   Median             35603                       24654                           25252            17944            17703            20417            44919            14668           37983
  (min-max)                   (1052--1.1x10E6)   (1315--286013)              (4051--7.2x10E6)                (2045--948785)   (1247--377892)   (1654--123586)   (3399--806926)   (1227--213290)   (543--566514)   
  *Clostridium* cluster I     Median             915                         642                             554              162              198              192              199              152             620
  (min-max)                   (3--207616)        (23--36102)                 (45--25647)                     (6--4116)        (6--1472)        (11--540)        (9--1988)        (11--791)        (2--497132)     
  *Clostridium* cluster XI    Median             1931                        1682                            1308             343              243              225              340              183             409
  (min-max)                   (28--99736)        (42--14942)                 (92--40735)                     (26--2769)       (2--2062)        (57--1645)       (18--3320)       (45--1415)       (18--3752)      
  Shannon diversity index     Median             2.68                        2.65                            2.68             2.56             2.62             2.71             2.59             2.54            2.68
  (min-max)                   (1.89--3.09)       (2.24--2.91)                (2.34--2.88)                    (1.93--2.95)     (0.68--3.01)     (2.30--3.05)     (2.36--2.88)     (2.01--3.02)     1.87--3.04)     

Regression splines showed statistically significant inverse associations between qPCR-determined microbial levels in mattress dust and atopy (0.7 kU/L) (p-values = 0.004--0.019; [Fig 2](#pone.0131594.g002){ref-type="fig"}). There was also a protective trend (p-value = 0.097) of high bacterial diversity (Shannon index) on atopy ([Fig 2](#pone.0131594.g002){ref-type="fig"}). Models with a linear exposure term fit better (AIC) than models without an exposure term or with a exposure modelled with a cubic spline term. Individual bacterial groups and diversity were not clearly associated with asthma. Protective effects were clearly visible in the whole study population and in the strata of exposed and unexposed non-farm children (controls). Effects were generally weakest or non-existent within the farm children (data not shown).

![Logistic regression analyses for microbial determinations and atopy.\
Survey weighted logistic regression analyses fitted with a cubic spline term for qPCR results (in cells/m2 dust) in mattress dust and probability of atopy (0.7kU/L) in the whole study population. 95% confidence intervals displayed as shaded bands. One extremely small value (outlier) for the Shannon diversity index (0.68) was excluded.](pone.0131594.g002){#pone.0131594.g002}

Discussion {#sec016}
==========

We show here that levels of *Mycobacterium* spp., *Bifidobacteriaceae* spp. and particularly of *Clostridium* spp. cluster XI and I are inversely associated with atopy. These associations were seen in qualitative analyses using DGGE and were further confirmed when targeting these specific bacterial groups using qPCR. The confirmation of the indicative associations seen in DNA fingerprinting with a second, quantitative methodology is a major strength of our study and advances previous work on indoor microbial factors in asthma and allergy. The associations we observed were between distinct bacterial groups and atopy, which would suggest the possibility of an association between single microbial species and these diseases. However, associations between the levels of these bacterial groups and atopy were all significant and could not be mutually adjusted because of the high correlations.

The risk for atopy as a response to specific bacterial levels and diversity varied among the exposure groups. For children living on a farm, the protective effect of higher levels was weak or non-existent. Clearest effects of bacterial exposures were seen in the unexposed control population. Within this exposure stratum, the highest levels of *Clostridium* cluster I and XI and *Mycobacterium* spp. were seen in non-asthmatic, non-atopic subjects. Farm children are generally exposed to higher microbial levels throughout pregnancy and early childhood compared to non-farm children \[[@pone.0131594.ref004],[@pone.0131594.ref022]\]. This more or less permanent, high-level exposure provides immune stimulus or challenge that probably protects from developing allergic disease later in life. This results in a population with high average microbial exposure levels, and lower prevalence of atopy. This might explain why an effect of high microbial levels within this sub-population might be more difficult to observe.

Levels of in particular *Clostridium* cluster XI and I, as well as *Mycobacterium* spp. were found to be highest in mattress dust from farm children. While *Clostridium* spp. are commonly found in the human intestinal tract, these bacteria are also present in other mammals and are abundant in milk products from farms. In particular *Clostridium* cluster I species are found in raw milk and milk products. Our findings suggest that these bacteria may represent exposures typically associated with farming environments. *Mycobacterium* spp. are less prevalent in humans or other animals, though some species are human and animal pathogens and endemically present in dairy cattle \[[@pone.0131594.ref023]\]. Sources of mycobacteria in house dust are manifold, including water, soil, aerosols and food. It is plausible that farming environments provide an additional rich source of this bacterial genus in house dust. *Bifidobacteriaceae* spp., on the other hand, occurred at comparably high levels in all exposure strata independent of farming environment contact, pointing towards the plausible relevance of the human source for this group of bacteria in mattress dust, though a clear source allocation cannot be provided here. *Bifidobacteriacea* spp. represent a major bacterial factor in the human intestinal flora and they are ubiquitous in the female vagina as well as the human oral flora. Nevertheless, members of this bacterial group is equally present in other mammals too. Interestingly, exposure to *Bifidobacterium* during the first year of life has---among other taxa determined from house dust in this respective study---been associated with less atopy in recent analyses of the Urban Environment and Childhood Asthma study in inner-city environments in several major cities in the United States \[[@pone.0131594.ref024]\].

The main objective of this study was to identify and quantitatively measure groups of bacteria which have associations with asthma and atopy and could possibly explain differences in prevalence of these diseases between rural and farm environments. Several recent papers \[[@pone.0131594.ref025]--[@pone.0131594.ref027]\] have synthesized the current knowledge on the farm effect and hygiene hypothesis; actual microbial factors underlying these phenomena have not been identified so far. While it is clear that exposure to microbes can influence the host immune system, protective effects of single microbial species in these diseases have been rarely explored. The findings in our study based on DNA fingerprinting of bacterial communities showed mostly inverse associations of individual bacterial signals with atopy and eczema, and much less so with asthma. Similarly, bacterial diversity in mattress dust in our study was protective for development of atopy, but not for asthma. This may for one partly be due to the limitation of small sample size. Ege et al. \[[@pone.0131594.ref011]\] reported inverse associations of fungal and bacterial diversity and specific microbial groups in house dust particularly with asthma, and only to a minor extent with atopy. It is relevant to explain here commonalities and differences between the earlier and this current study. Ege et al. presented results from two separate, complementary population studies: the PARSIFAL population consisted of children of farmers, children attending anthroposophic schools, and their respective reference groups living in rural and suburban areas of Bavaria. In the PARSIFAL study, Ege et al. focused on bacteria---as we did in our current study---and the main findings in PARSIFAL were that bacterial diversity and individual bacterial groups were inversely related to asthma, while findings were not significant for atopy. Differences in the study populations and in the molecular techniques applied may explain differences in the findings of PARSIFAL and our current study. The second population presented \[[@pone.0131594.ref011]\] were 450 subjects from the GABRIEL study population, which is overlapping with the one in our current analysis. However, the sample materials and especially the microbial determination methods differed fundamentally between the earlier and our current study. The earlier paper presented results on *viable* fungi and bacteria determined from airborne settled dust collected with an electrostatic dust collector. Inverse association of viable fungal diversity and specific fungal genera with asthma were highlighted, contrary to the bacterial focus in mattress dust in our current study. With respect to atopy, the presence of gram negative rods explained 30% of the effect of the farming environment on atopy. Our current study analysed specifically bacterial communities in mattress dust in a smaller sub-population of 214 study subjects of the GABRIEL survey. Here, we use DNA-based methodology that is not restricted to detection of viable cells only and targeted bacterial communities specifically. The differences in how and which aspects of the microbial exposures were assessed helps to explain why our study found more consistent associations of bacterial community factors with atopy, while the earlier study found associations of fungal groups and diversity with asthma. Our study presents quantitative confirmation of the qualitative findings from DNA fingerprinting, which has not been attempted in earlier studies. For this confirmation study we limited to targeting bacterial signals that had shown protective associations with atopy and eczema in DGGE.

While diversity within the human microbiome has been linked to several diseases \[[@pone.0131594.ref028]\], a possible impact of diversity in environmental microbial exposure on human health is much less explored. More diverse microbial exposure encountered in farm environments might have a protective quality in the development of allergic health outcomes \[[@pone.0131594.ref010]--[@pone.0131594.ref011]\]. The results of our study and earlier work on biodiversity and its interrelation with allergy support this hypothesis \[[@pone.0131594.ref029]\]. Improved measures of environmental microbial diversity will be provided by studies using next generation sequencing approaches that offer resolution of microbial communities at a very high level. It will be the subject of future research to investigate whether or not microbial diversity as such can explain beneficial effects on human health, or rather is a surrogate for a beneficial exposure situation.

We recognize certain limitations in the methodology of our study. Mattress dust is a convenient sample material in large epidemiological studies, but may not be the best sample to represent human exposure to environmental microbes. While bacterial content of mattress dust in urban homes is largely dominated by human-derived bacteria \[[@pone.0131594.ref030]\], this sample type, however, also reflects exposure to environmental microbes, for example farm contact \[[@pone.0131594.ref031]\]. A methodological limitation of virtually all DNA-based approaches that are currently being applied is that sequence fragments are limited in length, which typically prevents species level identification of microbial signals of interest. Since the rise of next generation sequencing approaches that now start to be used also in larger epidemiological studies on indoor microbial factors, the DNA fingerprinting method applied here may seem outdated, specifically due to limitations in resolution. However, the limitation that only the more abundant taxa of the microbial content and diversity in a sample are displayed in DGGE should equally be considered a strength, as these more abundant taxa likely also represent the more relevant groups from an exposure point of view. Increasing sequencing depth in next generation sequencing approaches is powerful, but also adds more of the less abundant and possibly not very etiologically-relevant bacterial taxa to the dataset, complicating a meaningful statistical analyses and identification of individual, relevant exposures. Despite this, there is little doubt that next generation sequencing approaches will be of great help in answering relevant questions on health effects of environmental microbial exposures.

In conclusion, this study adds to the body of evidence on protective qualities of microbial exposure in house dust, in particular observed for atopy. We succeeded in identifying bacterial signals that were more commonly found in mattress dust of non-atopic children. Within this study, we were able to confirm and specify these findings by quantifying the exposure to identified bacterial groups, which suggested protective associations for atopy, but not for asthma. High levels for *Clostridium* cluster I and XI and *Mycobacterium* spp. were seen in farming homes compared to non-farming homes. These findings suggest that these bacterial groups may contribute to a farm effect, offering protection from allergic health outcomes.
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